Results 171 to 180 of about 80,093 (283)

Progressive Cerebellar Atrophy Associated with a <i>KDM5C</i> Variant. [PDF]

open access: yesJMA J
Suzuki-Muromoto S   +12 more
europepmc   +1 more source

Kikuchi Fujimotos Disease: A Rare Case Report

open access: yesJK Science
Kikuchi Fujimotos disease is a rare variety of necrotising lymphadenitis. The condition is a rare, non-malignant, and self-limiting disorder that typically occurs in young adults of either sex.
Nanda Patil, Ghadge Neha, Prachi Patil
doaj  

Imaging of nanoscale polar textures in quantum paraelectric SrTiO<sub>3</sub>. [PDF]

open access: yesNature
Zhang Y   +7 more
europepmc   +1 more source

Linfadenitis histiocítica necrosante (enfermedad de Kikuchi-Fujimoto)

open access: yes, 2017
Introducción. La enfermedad de Kikuchi–Fujimoto es una linfadenitis histiocítica necrosante poco frecuente, sobre todo en la edad pediátrica. Caso clínico.
Lavalle Villalobos, Antonio   +4 more
core  

Comparative and functional anatomy of masticatory muscles and bite force in opossums (Didelphimorphia, Didelphidae)

open access: yesThe Anatomical Record, Volume 309, Issue 9, Page 2346-2367, September 2026.
We describe the functional anatomy of masticatory muscles in nine opossums, finding a generalized anatomical pattern with differences related to skull morphology. Variation in quantitative myological data and estimated bite force was mostly related to size, and the increase in bite force supports dietary diversification associated with size increase ...
Juann A. F. H. Abreu, Diego Astúa
wiley   +1 more source

Natural Compounds Targeting Oncogenic Signaling Networks in Glioblastoma: Molecular Mechanisms, Translational Advances, and Clinical Perspectives

open access: yesBrain and Behavior, Volume 16, Issue 9, September 2026.
Glioblastoma (GBM) is a highly aggressive brain tumor with a poor prognosis, driven by abnormal signaling pathways that promote growth and resistance to treatment. Conventional therapies are inadequate, highlighting the need for novel multitargeted approaches.
Mehrukh Zehravi   +13 more
wiley   +1 more source

Real‐World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Objectives To compare differences in clinical outcomes between dual immune checkpoint blockade and immunotherapy plus tyrosine kinase inhibitors (TKIs) as first‐line treatment for metastatic renal cell carcinoma in routine clinical practice. Patients and Methods Retrospective multicenter cohort study including 311 patients with International ...
Kojiro Ohba   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy